Oral Diabetes Drugs Show Large Increase in Medical Journal Advertising through November 2013

by Client Services

Print advertising pages in medical journals surpassed 88,280 through November 2013, a 5% decrease year-over-year, according to Kantar Media. Cancer Therapy Products continue to be the top drug class advertising by both pages and dollars, as it was in 2012. The Anticoagulants Oral class ranks second currently.

Top 5 Print Ad Drug Classes (Pages): Jan. – November 2013

#1 Cancer Therapy Products – 8,984 pages (+10%)

#2 Anticoagulants Oral – 3,702 pages (+32%)

#3 Diabetes Oral – 2,314 pages (+261%)

#4 Immunologic Agents – 1,696 pages (+105%)

#5 Biological Response Modifiers – 1,558 pages (+14%)

The percentage changes compare January – November 2013 to that same time period in 2012. For more information on these ad insights or other data, let one of us know.

Kantar Media sets the standard for accurate, comprehensive competitive advertising intelligence in the professional healthcare arena. Check back next month for updated data on the top products, classes, companies and category movers year-to-date.